Urenco Finance N.V. Publication of Base Prospectus (2809N)

TIDM44ZP

RNS Number : 2809N

Urenco Finance N.V.

30 May 2022

Publication of Base Prospectus

The following base prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Base Prospectus dated 27 May 2022 relating to a EUR 3,000,000,000 Euro Medium Term Note Programme of Urenco Finance N.V. as Issuer unconditionally and irrevocably guaranteed on a joint and several basis by Urenco Limited, Urenco UK Limited, Urenco Nederland B.V., Urenco Deutschland GmbH and Louisiana Energy Services.

To view the full document, please paste the following URL into the address bar of your browser.

https://www.urenco.com/cdn/uploads/supporting-files/Urenco_2022_-_Base_Prospectus_FINAL(259404528.2)_.pdf

For further information, please contact

Urenco Limited

Urenco Court

Sefton Park

Bells Hill

Stoke Poges

Bucks

SL2 4JS

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PDIFZGFKFGNGZZM

(END) Dow Jones Newswires

May 30, 2022 09:39 ET (13:39 GMT)

Urenco 24 (LSE:44ZP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024